Publications in collaboration with researchers from Hospital Universitario 12 de Octubre (9)

2025

  1. Allo-HCT refined ELN 2022 risk classification: validation of the Adverse-Plus risk group in AML patients undergoing allogeneic hematopoietic cell transplantation within the Spanish Group for Hematopoietic Cell Transplantation (GETH-TC)

    Blood Cancer Journal, Vol. 15, Núm. 1

  2. Early cardiac events after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide. subanalysis exploring cardiac toxicity conducted on behalf of GETH-TC

    Frontiers in Immunology, Vol. 16

2024

  1. Cardiac events after allo-HCT in patients with acute myeloid leukemia

    Blood Advances, Vol. 8, Núm. 21, pp. 5497-5509

  2. Cardiac events occurring after allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide. Study conducted on behalf of the GETH-TC

    Bone Marrow Transplantation, Vol. 59, Núm. 12, pp. 1694-1703

  3. Data-driven flow cytometry classification of blast differentiation in older patients with acute myeloid leukemia

    Blood Neoplasia, Vol. 1, Núm. 3

2023

  1. Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia

    Blood Advances, Vol. 7, Núm. 1, pp. 167-173

  2. Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia

    British Journal of Haematology

2022

  1. The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients

    Frontiers in Oncology, Vol. 12

2021

  1. Measurable residual disease in elderly acute myeloid leukemia: Results from the PETHEMA-FLUGAZA phase 3 clinical trial

    Blood Advances, Vol. 5, Núm. 3, pp. 760-770